Concepedia

Hervé Lebrec

HL

Statistics

Publications

23

Citations

604

H-Index

15

Active since

1994

Affiliations

Amgen (United States)(Current)

Université Paris-Saclay

Inserm

United States Food and Drug Administration

Research Triangle Park Foundation

Hervé Lebrec is an author at Amgen (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1994–2024

23

Publications

23

The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them

Martyn T. Smith, Kathryn Z. Guyton, Nicole Kleinstreuer et al. · Cancer Epidemiology Biomarkers & Prevention · 2020 · 101 citations · Full text

Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification

Dori R. Germolec, Hervé Lebrec, Stacey E. Anderson et al. · Environmental Health Perspectives · 2022 · 50 citations · Full text

Evaluation of a Lymph Node Proliferation Assay for its Ability to Detect Pharmaceuticals with Potential to Cause Immune-Mediated Drug Reactions

James L. Weaver, Joan M. Chapdelaine, Jacques Descotes et al. · Journal of Immunotoxicology · 2005 · 40 citations · Full text

Summary of a workshop on preclinical and translational safety assessment of CD3 bispecifics

Cris Kamperschroer, Jacintha Shenton, Hervé Lebrec et al. · Journal of Immunotoxicology · 2020 · 40 citations · Full text

, , +14

Homeostasis of Human NK Cells Is Not IL-15 Dependent

Hervé Lebrec, Michelle Horner, Kevin Gorski et al. · The Journal of Immunology · 2013 · 38 citations

1–5 of 23